Skip to main content
TipRanks
Go Ultimate75% OFF

Amneal Pharmaceuticals (AMRX) Q4 2025 Earnings Report

638 Followers

AMRX Q4 2025 EPS Results

Actual EPS
$0.21
Consensus EPS
$0.18
Beat/Miss
Beat by +$0.03
One Year Ago EPS
$0.12

AMRX Q4 2025 Revenue Results

Actual Revenue
$814.32M
Expected Revenue
$807.35M
Beat/Miss
Beat by +$6.96M
YoY Revenue Growth
+11.47%

Earnings Announcement Details

Quarter
Q4 2025
Date
02/27/2026
Time
Before Open
Conference Call
Friday, February 27, 2026
AMRX Upcoming Earnings

Amneal Pharmaceuticals's next earnings date is estimated for February 26, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

AMRX Q4 2025 Earnings Call
0:00 / 0:00

Q4 2025 Earnings Slide Deck

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

AMRX Earnings History

AMRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 26, 20272026 (Q4)0.24-0.21――
Nov 03, 20262026 (Q3)0.240.260.1752.94% (+0.09)
Jul 30, 20262026 (Q2)0.220.300.2520.00% (+0.05)
May 07, 20262026 (Q1)0.170.270.2128.57% (+0.06)
Feb 27, 20262025 (Q4)0.180.210.1275.00% (+0.09)
Oct 30, 20252025 (Q3)0.140.170.166.25% (+0.01)
Aug 05, 20252025 (Q2)0.170.250.1656.25% (+0.09)
May 02, 20252025 (Q1)0.150.210.1450.00% (+0.07)
Feb 28, 20252024 (Q4)0.150.120.14-14.29% (-0.02)
Nov 08, 20242024 (Q3)0.130.160.19-15.79% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed